Cyclopharm News

Cyclomedica will exhibit at the EANM 2019 Congress

1st Mar 2019

Continue Reading

Our 4th million Patient Administration Set has been manufactured

31st May 2018

Continue Reading

New clinical trial to develop better tools for asthma and COPD

18th May 2018

Continue Reading

First 40 patients’ milestone reached in USFDA Phase 3 Technegas study

29th Mar 2018

Continue Reading

Cyclopharm (ASX.CYC) Presentation, FNN Investor Event, Dec 2017, Sydney

20th Dec 2017

Continue Reading

CEO & MD, James McBrayer talks lung disease screening

19th Dec 2017

Continue Reading

Nuclear imaging trial aiming to clear up airway diagnosis

12th Oct 2017

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Cum sociis Continue Reading

Advancing Molecular Imaging in NSW

12th Oct 2017

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Cum sociis Continue Reading

Cyclopharm’s USFDA Technegas Clinical Trial – Patient Enrolment Underway

28th Sep 2017

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Cum sociis Continue Reading

Cyclopharm Acquires European Distribution Business

12th Aug 2017

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Cum sociis Continue Reading